4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-050841
Options or other derivatives
- SVP, Chief Accounting Officer acquired 2,351 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Huizenga Theodore Alan SVP, Chief Accounting Officer | 2023-09-27 | Grant or award · Stock Option (Right to Buy) | +2,351 | 2,351 | D: show line 1 in the form |
Loading xslF345X05/doc4.xml…